Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum In New York
3/17/2014 8:36:37 AM
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Vikas Sharma, Ph.D., the Company’s Director, Business Development, will present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York on Wednesday, March 19, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by